Skip to content

Clinical trials

Phase 2 Scleroderma, Systemic trials in Poland

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Scleroderma, Systemic Phase: Phase 2 Country / region: Poland Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20081
20101
20121
20162
20201
20211
20222
20241
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Terminated3
Active, not recruiting2
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
ISDIN2
Amgen1
Artiva Biotherapeutics, Inc.1
Boehringer Ingelheim1
Celgene1
Certa Therapeutics1
EMD Serono Research & Development Institute, Inc.1
Gesynta Pharma AB1
Pfizer1
Sanofi1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Scleroderma, Systemic13
Scleroderma, Diffuse5
Lung Diseases, Interstitial3
Arthritis, Rheumatoid1
Autoimmune Diseases1
Immune System Diseases1
Myositis1
Peripheral Vascular Diseases1
Raynaud Disease1
Sjogren's Syndrome1

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.